Roberta Kline MD
OP/ED: How 23andMe Will Affect Your Medical Practice
On April 30, 2017, the Wall Street Journal published a column, Personalized Medicine is Here, on the Food and Drug Administration’s recent approval of 10 screening tests for the company 23andMe. The authors Peter Huber and Paul Howard, who are senior fellows at the Manhattan Institute, write: “We applaud theRead